Brain Cancer

8 protocols meet the specified criteria.

  • A151804

    Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events

  • A211901

    Reaching Rural Cancer Survivors Who Smoke Using Test-Based Cessation Interventions

  • COG-ANBL2131

    A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma

  • EAF223

    GABLE: Phase II Glioblastoma Accelerated Biomarkers Learning Environment Trial

  • EAY191

    Molecular Analysis for Combination Therapy Choice (ComboMATCH)

  • F8394-201

    A Phase 2 Master Protocol to assess the efficacy and safety of FORE8394, an inhibitor of BRAF class 1 and class 2 alterations, in participants with cancer harboring BRAF alterations

  • GRAIL-MA-002

    REACH Study: Real-world Evidence to Advance Multi-Cancer Early Detection Health Equity (REACH/Galleri-Medicare study)

  • WVU011625

    The role of scheduled intravenous fluids in the supportive management of patients undergoing chemo-radiotherapy for head and neck cancers